Mochida Pharmaceutical Co., Ltd. (4534) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mochida Pharmaceutical Co., Ltd. (4534:JPX), powered by AI.

Current Price
¥3,150
P/E Ratio
19.6
Market Cap
111.7B
Sector
Healthcare
What is the Mochida Pharmaceutical Co., Ltd. stock price forecast?

Mochida Pharmaceutical Co., Ltd. is currently trading at ¥3,150. View real-time AI analysis on Alpha Lenz.

What is Mochida Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Mochida Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Mochida Pharmaceutical Co., Ltd.'s P/E ratio?

Mochida Pharmaceutical Co., Ltd.'s P/E ratio is 19.6.

Mochida Pharmaceutical Co., Ltd.

JPX · 4534
¥3,150-50(-1.56%)Market closedJPX regular session 09:00–15:00 JST
Ask about Mochida Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Mochida Pharmaceutical Co., Ltd. trades at a P/E of 19.6 (fair value) with modest ROE of 4.4%.

Ask for details

Company Overview

Mochida Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, focused on the research, development, and manufacturing of a diverse range of medical products. Primarily, the company engages in creating prescription drugs, covering therapeutic areas such as oncology, cardiology, and dermatology, which are critical for patient treatments worldwide. Additionally, it extends its expertise into over-the-counter medications, diagnostic agents, and healthcare products. A notable feature of Mochida Pharmaceutical is its emphasis on R&D, reflected in its development of innovative therapies aimed at addressing unmet medical needs. Within the financial market, Mochida Pharmaceutical holds significance as a key player in Japan's robust healthcare sector. As a steadfast contributor to the pharmaceutical landscape, the company supports global health advancement through strategic partnerships and collaborations, driving forward medical science and patient care.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,508

Company Statistics

FY 2025

Profile

¥111,672,174,600Market Cap
¥105,159,000,000Revenue
0.00Shares Out
1,508Employees

Margins

51.15%Gross
10.47%EBITDA
7.73%Operating
7.66%Pre-Tax
5.41%Net

Valuation

19.64P/E
0.85P/B
1.06EV/Sales
6.04EV/EBITDA
15.52P/FCF

Growth (CAGR)

-1.54%Rev 3Yr
0.65%Rev 5Yr
-17.35%Op Inc 3Yr
-1.60%Op Inc 5Yr
-18.67%Net Inc 3Yr
4.34%Net Inc 5Yr

Returns

3.57%ROA
4.40%ROE
5.05%ROIC

Financial Health

¥45,154,000,000Cash & Cash Equivalents
¥-15,726,000,000Net Debt
22.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Mochida Pharmaceutical Co., Ltd. (ticker: 4534) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,508 employees. Market cap is $111.7B.

The current price is 3,150 with a P/E ratio of 19.64x and P/B of 0.85x.

ROE is 4.40% and operating margin is 7.73%. Annual revenue is $105.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Mochida Pharmaceutical Co., Ltd. (4534) Stock Forecast 2026 ¥3,150 — Price, Financials & Analyst Targets | Alpha Lenz